Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
02/2000
02/17/2000CA2339340A1 Antisense oligonucleotides for the inhibition of vegf expression
02/17/2000CA2339194A1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders
02/17/2000CA2339086A1 Dna replication- and repair-associated proteins
02/17/2000CA2338855A1 Indole spla2 inhibitors
02/17/2000CA2338385A1 Human receptor-associated proteins
02/17/2000CA2338121A1 Amide derivatives useful as inhibitors of the production of cytokines
02/17/2000CA2338035A1 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid
02/17/2000CA2337964A1 Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides
02/16/2000EP0979869A1 Short oligonucleotides for the inhibition of VEGF expression
02/16/2000EP0979654A1 Activated vitamin d 3? emulsion-type lotions
02/16/2000EP0979228A1 Novel cannabinoid receptor agonists
02/16/2000EP0979099A1 Use of lactoferin in the treatment of allergen induced disorders
02/16/2000EP0979085A1 Treatment of eosinophil-associated pathologies, such as bronchial asthma, with synergistic combinations of glucocorticoids and a local anesthetics
02/16/2000EP0979078A1 Substituted bis-acridines and related compounds as ccr5 receptor ligands, anti-inflammatory agents and anti-viral agents
02/16/2000EP0979066A2 Cosmetic particulate gel carriers for topically applied active agents
02/16/2000EP0979065A1 Use of oligosaccharides for the treatment of connective tissues
02/16/2000CN1244873A Antibodies that bind to the nidogen-binding domain of laminin, their production and use
02/16/2000CN1244870A Tissue specific expression of retinoblastoma protein
02/16/2000CN1244800A Remedy for axillary osmidrosis containing adrenocorticosteriodal preparation
02/16/2000CN1244796A Pellets having a core coated with an antifungal and a polymer
02/16/2000CN1244428A Fast-acting burn and scald treating liquid
02/16/2000CN1244417A Leukoderma curing medicine
02/16/2000CN1244392A Externally used medicine for treating tinea
02/16/2000CN1049423C 芳香羧酸衍生物 Aromatic carboxylic acid derivatives
02/15/2000US6025446 Wound healing agent with sensitivity; equilibrium controlled diffusion
02/15/2000US6025388 Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids
02/15/2000US6025334 Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
02/15/2000US6024940 Antiinflammatory agents for mammals
02/10/2000WO2000006730A2 Human cytoskeletal proteins
02/10/2000WO2000006709A1 Human protein kinase h2lau20
02/10/2000WO2000006698A1 98 human secreted proteins
02/10/2000WO2000006694A2 Compound and method for the prevention and/or the treatment of allergy
02/10/2000WO2000006604A2 Use of cd25 binding molecules in the treatment of rheumatoid arthritis or skin diseases
02/10/2000WO2000006589A1 Prostate derived ets factor
02/10/2000WO2000006588A1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS
02/10/2000WO2000006563A1 Substituted imidazoles having cytokine inhibitory activity
02/10/2000WO2000006561A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
02/10/2000WO2000006190A1 THYMOSIN β4 PROMOTES WOUND REPAIR
02/10/2000WO2000006188A1 Hair growth/maintenance compositions and methods involving the same
02/10/2000WO2000006187A2 Modulation of apoptosis
02/10/2000WO2000006185A2 Methods of using lanreotide, a somatostatin analogue
02/10/2000WO2000006181A1 A medicament for treating recurrent ulcer of mouth and behcet's syndrome
02/10/2000WO2000006180A1 Composition for stimulating the synthesis of the melanic pigment and process for obtaining it
02/10/2000WO2000006167A1 Tricyclic compounds
02/10/2000WO2000006153A1 Propenamides as ccr5 modulators
02/10/2000WO2000006146A1 Substituted anilide compounds and methods
02/10/2000WO2000006145A1 Methods for treating conditions modulated by lactosylceramide
02/10/2000WO2000006115A1 Topical compositions containing sialyl sugars and their derivatives
02/10/2000WO2000006091A1 Novel uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same
02/10/2000WO2000006085A2 Compounds and methods
02/10/2000WO2000006074A1 Apparatus for the application of ozone/oxygen for the treatment of external pathogenic conditions
02/10/2000WO2000000510A8 Growth factor modulators
02/10/2000WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors
02/10/2000WO1999049039A3 GFRα3 AND ITS USES
02/10/2000WO1999042481A3 AGENTS FOR TREATING HUMAN ILLNESSES BASED ON β-CATENIN, AND THE PRODUCTION AND USE THEREOF
02/10/2000CA2339301A1 Hdpbo81 nucleic acids and polypeptides
02/10/2000CA2339096A1 Modulation of apoptosis
02/10/2000CA2338928A1 Thymosin .beta.4 promotes wound repair
02/10/2000CA2338804A1 Propenamides as ccr5 modulators
02/10/2000CA2338797A1 Hair growth/maintenance compositions and methods involving the same
02/10/2000CA2338764A1 Substituted anilide compounds and methods
02/10/2000CA2338697A1 Compounds and methods
02/10/2000CA2338298A1 Tricyclic compounds
02/10/2000CA2338019A1 Prostate derived ets factor
02/10/2000CA2336549A1 Methods for treating conditions modulated by lactosylceramide
02/10/2000CA2336526A1 Composition for stimulating the synthesis of the melanic pigment and process for obtaining it
02/10/2000CA2335656A1 Human cytoskeletal proteins
02/10/2000CA2335654A1 Methods of using a somatostatin analogue
02/10/2000CA2335077A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
02/10/2000CA2333854A1 Stereoisomers of cpg oligonucleotides and related methods
02/10/2000CA2306010A1 Apparatus for the application of ozone/oxygen for the treatment of external pathogenic conditions
02/10/2000CA2304881A1 Topical compositions containing sialyl sugars and their derivatives
02/10/2000CA2304596A1 A medicament for treating recurrent ulcer of mouth and behcet's syndrome
02/09/2000EP0978561A1 Antisense oligonucleotides for the inhibition of VEGF expression
02/09/2000EP0977854A2 Truncated vegf-related proteins
02/09/2000EP0977749A1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same
02/09/2000EP0977745A1 Thioaryl sulfonamide hydroxamic acid compounds
02/09/2000EP0977734A2 Arylsecocholadiene derivatives
02/09/2000EP0977733A1 Arylsulfonylamino hydroxamic acid derivatives
02/09/2000EP0977569A1 Pharmaceutical composition for supressing type 2 helper t cell immune response
02/09/2000EP0977568A1 Benzocycloheptathiophene compounds
02/09/2000EP0977565A1 Pharmaceutical composition
02/09/2000EP0977550A1 Use of at least an irvingia gabonensis extract in a cosmetic and/or pharmaceutical product
02/09/2000EP0977544A1 Personal care compostions comprising a silicone-containing adhesive copolymer
02/09/2000EP0977543A1 Personal care compositions comprising an adhesive copolymer
02/09/2000CN1244128A Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens
02/09/2000CN1244121A Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides
02/09/2000CN1243827A Preparation of heterocyclic amide derivative with specific physical status
02/09/2000CN1243735A Skin regrowing powder and its preparing process
02/09/2000CN1243724A Oral medicine for treating dermatosis
02/09/2000CN1243703A Snake wine
02/09/2000CN1243701A Use of cholesterol liquid crystal composition in cosmetics and pharmaceutical preparation
02/09/2000CN1049214C Phenylimidazolidines, process for their preparation, their use as medicament and pharmaceutical compositions containing them.
02/08/2000US6022978 Benzimidazole derivatives
02/08/2000US6022971 Azetidines
02/08/2000US6022969 Symmetrical bis(aminoalkyl), bis(amidinoalkyl) and bis(guanidinoalkyl) cycloalkanes
02/08/2000US6022898 Metalloproteinase inhibitors
02/08/2000US6022896 Petroselinic acid as an anti-irritant in compositions containing alpha-hydroxy acids
02/08/2000US6022884 Substituted pyridine compounds and methods of use
02/08/2000US6022862 Use of pseudopterosins for promoting wound healing
1 ... 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 ... 1065